Evaluation of the Serum Zinc Level in Patients Followed in Hospital with the Diagnosis of COVID-19 in Samsun Province, Türkiye
Hacer İşler, İlkay Bahçeci, Seda Güdül Havuz, Seher Aydoğan, Göksenin Ünlügüzel Üstün, Çağatay Erman Öztürk, Eşe Başbulut
Life and Medical Sciences, doi:10.54584/lms.2023.39
The COVID-19 (Coronavirus Disease 2019) outbreak has not yet ended and poses a persistent hazard to individuals, communities, and healthcare systems globally. Similar to numerous other diseases, the immune system of the patient is intricately associated with the advancement and mortality rates of COVID-19. In general, the immune system plays a crucial role in protecting the host against infections and neoplastic cells, and a well-balanced diet can enhance the immune system's ability to effectively defend against infectious agents. There have been suggestions that the administration of zinc supplements may decrease the occurrence of lower respiratory tract infections in children who are deficient in zinc. This study will thus examine the potential of zinc as a preventive and therapeutic agent, either on its own or in conjunction with other techniques, as zinc fulfills all the requirements outlined above. The study cohort was stratified into three distinct groups, namely critical care patients, service patients, and a healthy control group; a total of 24 COVID-19 patients in critical care, 27 ward-treated COVID-19 patients, and 26 healthy individuals. The groups exhibited a notable disparity in age distribution (p<0.001). A statistically significant difference was seen among the groups in relation to the survey results, presence of chronic disease, and length of hospital stay (p<0.001, p<0.001, and p=0.007, respectively). COVID-19 patients (n=51) exhibited markedly reduced zinc levels in comparison to a control group of healthy individuals (n=26). It was observed that the average zinc level in patients diagnosed with COVID-19 was 89 μg/dl (range: 43-123 μg/dl). In comparison, the median zinc level in individuals without COVID-19 was found to be 99.5 μg/dl (range: 79-125 μg/dl). A statistically significant difference was observed between the groups (p=0.023). The study revealed that a total of 13 individuals, accounting for 25.5% of the COVID-19 patients, exhibited a deficiency in zinc levels. The findings of our study ©Copyright LMS.
Conflict of interest: The authors declare that there is no conflict of interest. The authors alone are responsible for the content and writing of the paper. Financial disclosure: There is no financial support for this study.
References
Akdeniz, Kınık, Yerlikaya, Akan, Importance of Zinc in Human Health and Nutrition Physiology, Academic Food Journal
Barocas, So-Armah, Cheng, Lioznov, Baum et al., Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected antiretroviral naïve persons with alcohol use in Russia, PLoS One,
doi:10.1371/journal.pone.0218852Boyraz, Alataş, Toğuç, Delen, Çavdar et al., The Effect of Mediterranean Diet Compliance on COVID-19 Symptoms and Disease Severity, J Mol Virol Immunol,
doi:10.46683/jmvi.2022.55Brown, Ojha, Fricke, Sa, Imarogbe et al., Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms, Vaccines,
doi:10.3390/vaccines11020408Devaux, Rolain, Raoult, ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome, J Microbiol Immunol Infect,
doi:10.1016/j.jmii.2020.04.015Gupta, Read, Shackel, Hebbard, George et al., The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus, Cells,
doi:10.3390/cells8060603Jothimani, Kailasam, Danielraj, Nallathambi, Ramachandran et al., COVID-19: Poor outcomes in patients with zinc deficiency, Int J Infect Dis,
doi:10.1016/j.ijid.2020.09.014Lassi, Moin, Bhutta, Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months, Cochrane Database Syst Rev,
doi:10.1002/14651858.CD005978.pub3Patel, Chinni, El-Khoury, Perera, Neto et al., A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients, J Med Virol,
doi:10.1002/jmv.26895Yasui, Yasui, Suzuki, Saitou, Yamamoto et al., Analysis of the predictive factors for a critical illness of COVID-19 during treatment -relationship between serum zinc level and critical illness of COVID-19, Int J Infect Dis,
doi:10.1016/j.ijid.2020.09.008Şenol, Şakul, COVID-19 and Support Products: The Effects of Nutritional Immunity, J Mol Virol Immunol,
doi:10.46683/jmvi.2023.66
